See more : Technology Metals Australia Limited (TMT.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Hunan Jingfeng Pharmaceutical Co.,Ltd. (000908.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Hunan Jingfeng Pharmaceutical Co.,Ltd., a leading company in the Drug Manufacturers – General industry within the Healthcare sector.
You may be interested
- PAO NOVATEK (NVTK.ME) Income Statement Analysis – Financial Results
- LARK Distilling Co. Ltd. (LRKKF) Income Statement Analysis – Financial Results
- Ilshin Spinning Co.,Ltd (003200.KS) Income Statement Analysis – Financial Results
- Log-In Logística Intermodal S.A. (LOGN3.SA) Income Statement Analysis – Financial Results
- PARK24 Co., Ltd. (PKCOF) Income Statement Analysis – Financial Results
Hunan Jingfeng Pharmaceutical Co.,Ltd. (000908.SZ)
About Hunan Jingfeng Pharmaceutical Co.,Ltd.
Hunan Jingfeng Pharmaceutical Co.,Ltd. manufactures and sells chemical drugs and biological agents in China. The company's principal product is sodium hyaluronate injection for use in orthopedics and surgery applications. It also offers ophthalmology and API products, as well as engages in the research and development of anti-tumor, cancer, and cardiovascular drugs; and provides skin care products. The company was founded in 2003 and is headquartered in Shanghai, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 656.89M | 840.66M | 811.18M | 877.92M | 1.34B | 2.59B | 2.58B | 2.64B | 2.46B | 1.96B | 167.31M | 145.27M | 139.03M | 217.39M | 236.38M | 216.80M | 187.73M | 237.63M | 214.42M | 258.57M | 217.13M | 214.45M | 171.25M | 189.27M | 135.99M | 86.38M | 65.89M | 68.59M | 67.47M |
| Cost of Revenue | 185.52M | 199.67M | 307.98M | 318.42M | 537.07M | 629.39M | 552.31M | 559.26M | 463.52M | 289.09M | 131.61M | 121.98M | 118.74M | 181.06M | 242.09M | 186.46M | 161.21M | 170.20M | 160.88M | 232.70M | 204.72M | 165.60M | 138.02M | 133.56M | 82.41M | 48.03M | 36.97M | 46.30M | 49.31M |
| Gross Profit | 471.37M | 640.99M | 503.21M | 559.50M | 806.96M | 1.96B | 2.03B | 2.08B | 2.00B | 1.67B | 35.70M | 23.29M | 20.29M | 36.33M | -5.71M | 30.35M | 26.53M | 67.42M | 53.54M | 25.87M | 12.41M | 48.85M | 33.23M | 55.71M | 53.58M | 38.36M | 28.92M | 22.29M | 18.16M |
| Gross Profit Ratio | 71.76% | 76.25% | 62.03% | 63.73% | 60.04% | 75.66% | 78.62% | 78.82% | 81.15% | 85.23% | 21.34% | 16.03% | 14.59% | 16.71% | -2.42% | 14.00% | 14.13% | 28.37% | 24.97% | 10.00% | 5.72% | 22.78% | 19.40% | 29.43% | 39.40% | 44.40% | 43.89% | 32.49% | 26.91% |
| Research & Development | 52.51M | 35.64M | 38.63M | 252.88M | 191.30M | 156.36M | 93.21M | 82.10M | 80.11M | 61.95M | 62.54M | 36.30M | 2.90M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 92.56M | 59.30M | 138.08M | 82.78M | 95.89M | 69.46M | 76.63M | 100.38M | 101.50M | 103.14M | 8.04M | 10.25M | 12.16M | 10.70M | 41.62M | 33.39M | 22.05M | 27.82M | 21.03M | 50.19M | 30.23M | 21.25M | 18.83M | 11.52M | 7.38M | 6.42M | 3.90M | 6.59M | 6.25M |
| Selling & Marketing | 320.82M | 421.88M | 455.29M | 596.08M | 906.51M | 1.20B | 1.35B | 1.24B | 1.22B | 1.08B | 12.78M | 13.35M | 14.54M | 14.66M | 16.74M | 10.88M | 7.15M | 7.62M | 9.34M | 10.96M | 11.25M | 12.03M | 14.65M | 8.02M | 4.84M | 2.99M | 1.94M | 2.04M | 1.65M |
| SG&A | 413.38M | 481.18M | 593.37M | 678.87M | 1.00B | 1.27B | 1.43B | 1.34B | 1.32B | 1.19B | 20.83M | 23.59M | 26.71M | 25.37M | 58.36M | 44.27M | 29.20M | 35.44M | 30.36M | 61.16M | 41.48M | 33.28M | 33.48M | 19.54M | 12.22M | 9.41M | 5.84M | 8.63M | 7.89M |
| Other Expenses | 178.40M | 107.31M | 129.42M | 142.24M | 168.55M | -11.17M | -8.26M | 30.73M | 18.13M | 13.10M | 2.10M | 872.91K | 18.42M | 27.05M | -7.34M | 3.11M | 5.89M | 2.04M | 1.69M | 1.76M | -7.95M | 5.70M | 4.10M | 6.47M | 2.28M | 1.05M | 1.56M | 2.22M | 838.06K |
| Operating Expenses | 644.29M | 624.14M | 761.42M | 1.07B | 1.36B | 1.60B | 1.68B | 1.57B | 1.52B | 1.34B | 42.86M | 47.88M | 54.82M | 46.75M | 61.45M | 45.91M | 30.55M | 36.63M | 31.34M | 62.22M | 42.40M | 34.61M | 34.11M | 20.29M | 12.66M | 10.11M | 6.13M | 8.86M | 8.11M |
| Cost & Expenses | 829.80M | 823.80M | 1.07B | 1.39B | 1.90B | 2.23B | 2.23B | 2.13B | 1.99B | 1.63B | 174.47M | 169.86M | 173.56M | 227.81M | 303.54M | 232.36M | 191.75M | 206.84M | 192.22M | 294.92M | 247.12M | 200.21M | 172.13M | 153.85M | 95.07M | 58.14M | 43.11M | 55.17M | 57.43M |
| Interest Income | 1.21M | 1.12M | 567.77K | 1.44M | 6.65M | 2.23M | 3.71M | 2.71M | 2.56M | 758.20K | 277.30K | 96.94K | 312.41K | 612.40K | 586.13K | 1.44M | 1.79M | 1.17M | 1.23M | 2.79M | 4.67M | 1.78M | 2.68M | 3.87M | 0.00 | -0.46 | -0.36 | -0.74 | -0.31 |
| Interest Expense | 39.93M | 52.40M | 86.09M | 106.15M | 105.02M | 84.62M | 93.45M | 68.45M | 49.84M | 28.51M | 6.14M | 20.36M | 19.83M | 19.91M | 30.94M | 28.93M | 24.70M | 29.89M | 21.82M | 23.25M | 16.29M | 9.32M | 7.42M | 8.65M | 0.00 | 2.14M | 2.43M | 2.52M | 3.02M |
| Depreciation & Amortization | 44.46M | 60.39M | 123.67M | 113.33M | 98.76M | 104.75M | 86.50M | 66.50M | 41.73M | 27.50M | 8.31M | 8.80M | 9.09M | 9.81M | 19.15M | 15.65M | 11.07M | 11.94M | 10.70M | 10.44M | 12.49M | 9.89M | 6.90M | 5.57M | 4.42M | -5.03M | -4.91M | -6.07M | 858.12K |
| EBITDA | -89.27M | 22.00M | 58.11M | -924.83M | -703.13M | 395.78M | 437.33M | 536.00M | 483.77M | 364.31M | 190.83M | -31.79M | -27.46M | 32.76M | -187.88M | 12.73M | 40.57M | 45.59M | 36.18M | -31.11M | -21.41M | 36.45M | 26.25M | 61.97M | 45.34M | 27.38M | 22.78M | 13.43M | 10.05M |
| EBITDA Ratio | -13.59% | 8.31% | 10.60% | -27.12% | -31.04% | 16.86% | 16.08% | 22.80% | 21.81% | 18.97% | 14.42% | -10.31% | -18.96% | 19.74% | -24.83% | 7.82% | 23.87% | 18.80% | 16.87% | -12.03% | -9.86% | 17.00% | 15.33% | 36.10% | 33.34% | 32.69% | 34.58% | 19.57% | 14.89% |
| Operating Income | -104.38M | 14.47M | -21.47M | -514.48M | -555.28M | 254.93M | 258.11M | 440.92M | 415.75M | 293.59M | 2.46M | -61.95M | -55.20M | -24.01M | -230.59M | -34.99M | -1.10M | 1.61M | 2.73M | -67.17M | -50.93M | 16.34M | 12.20M | 52.76M | 64.04M | 33.28M | 27.69M | 19.49M | 9.19M |
| Operating Income Ratio | -15.89% | 1.72% | -2.65% | -58.60% | -41.31% | 9.86% | 9.99% | 16.70% | 16.91% | 15.00% | 1.47% | -42.64% | -39.70% | -11.05% | -97.55% | -16.14% | -0.58% | 0.68% | 1.27% | -25.98% | -23.46% | 7.62% | 7.12% | 27.87% | 47.09% | 38.52% | 42.03% | 28.42% | 13.62% |
| Total Other Income/Expenses | -69.29M | -66.19M | -130.63M | -529.31M | -364.49M | -63.08M | -78.36M | -38.18M | -26.98M | -14.72M | -46.83M | -23.50M | -20.77M | 27.05M | -170.80M | -16.56M | 5.89M | -27.93M | -19.31M | -27.83M | 740.04K | 897.24K | -270.62K | 1.11M | 1.31M | 140.55K | 445.38K | 1.05M | -206.35K |
| Income Before Tax | -173.67M | -90.56M | -155.44M | -1.15B | -919.77M | 243.76M | 249.85M | 470.59M | 433.70M | 306.09M | 3.29M | -61.08M | -56.38M | 3.03M | -237.97M | -32.12M | 4.80M | 2.85M | 3.65M | -64.80M | -50.19M | 17.23M | 11.93M | 54.11M | 65.35M | 33.42M | 28.14M | 20.55M | 8.98M |
| Income Before Tax Ratio | -26.44% | -10.77% | -19.16% | -131.21% | -68.43% | 9.43% | 9.67% | 17.82% | 17.64% | 15.64% | 1.96% | -42.04% | -40.55% | 1.40% | -100.67% | -14.81% | 2.56% | 1.20% | 1.70% | -25.06% | -23.12% | 8.04% | 6.97% | 28.59% | 48.05% | 38.69% | 42.71% | 29.95% | 13.31% |
| Income Tax Expense | 32.84M | 10.33M | 46.20M | 3.39M | 1.78M | 45.23M | 64.63M | 82.48M | 63.51M | 48.68M | -130.77K | -130.77K | 675.68K | 102.67K | 6.06M | -177.38K | -956.01K | 186.53K | 690.30K | 506.95K | 2.15M | 3.10M | 904.43K | 7.79M | 8.53M | 4.07M | 1.28M | 1.88M | 1.02M |
| Net Income | -215.14M | -100.89M | -201.64M | -1.16B | -921.55M | 186.81M | 162.09M | 340.03M | 324.10M | 251.03M | 3.37M | -60.80M | -56.97M | 2.99M | -238.45M | -33.49M | 5.65M | 2.73M | 2.97M | -65.08M | -52.77M | 14.02M | 12.25M | 46.25M | 56.80M | 29.34M | 26.85M | 18.66M | 7.96M |
| Net Income Ratio | -32.75% | -12.00% | -24.86% | -131.60% | -68.57% | 7.22% | 6.27% | 12.88% | 13.18% | 12.82% | 2.01% | -41.85% | -40.98% | 1.38% | -100.88% | -15.45% | 3.01% | 1.15% | 1.39% | -25.17% | -24.30% | 6.54% | 7.15% | 24.44% | 41.77% | 33.97% | 40.76% | 27.21% | 11.80% |
| EPS | -0.24 | -0.11 | -0.23 | -1.31 | -1.05 | 0.21 | 0.18 | 0.39 | 0.37 | 0.50 | 0.26 | -0.20 | -0.19 | 0.01 | -0.77 | -0.10 | 0.02 | 0.01 | 0.01 | -0.17 | -0.13 | 0.04 | 0.03 | 0.10 | 0.15 | 0.07 | 0.07 | 0.05 | 0.02 |
| EPS Diluted | -0.24 | -0.11 | -0.23 | -1.31 | -1.05 | 0.21 | 0.18 | 0.39 | 0.37 | 0.50 | 0.26 | -0.20 | -0.19 | 0.01 | -0.77 | -0.10 | 0.02 | 0.01 | 0.01 | -0.17 | -0.13 | 0.04 | 0.03 | 0.10 | 0.15 | 0.07 | 0.07 | 0.05 | 0.02 |
| Weighted Avg Shares Out | 879.93M | 879.77M | 879.77M | 879.77M | 879.77M | 879.77M | 879.77M | 879.76M | 875.95M | 502.06M | 512.88M | 308.04M | 307.95M | 307.56M | 308.00M | 334.89M | 310.97M | 391.82M | 391.82M | 391.82M | 391.82M | 391.82M | 391.82M | 391.82M | 391.82M | 391.82M | 391.82M | 391.82M | 391.82M |
| Weighted Avg Shares Out (Dil) | 879.93M | 879.77M | 879.77M | 879.77M | 879.77M | 879.95M | 879.94M | 879.76M | 875.95M | 502.06M | 512.88M | 308.04M | 307.95M | 307.56M | 308.00M | 334.89M | 310.97M | 391.82M | 391.82M | 391.82M | 391.82M | 391.82M | 391.82M | 391.82M | 391.82M | 391.82M | 391.82M | 391.82M | 391.82M |
No news found for: 000908.SZ
Source: https://incomestatements.info
Category: Stock Reports